Dr. Larry Glazerman, MD

NPI: 1356397574
Total Payments
$40,552
2024 Payments
$3,010
Companies
11
Transactions
45

Payment Breakdown by Category

Consulting$19,183 (47.3%)
Other$14,950 (36.9%)
Travel$4,707 (11.6%)
Food & Beverage$1,680 (4.1%)
Education$32.27 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $19,183 10 47.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,250 4 32.7%
Travel and Lodging $4,707 9 11.6%
Food and Beverage $1,680 19 4.1%
Honoraria $1,500 1 3.7%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $200.00 1 0.5%
Education $32.27 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Hologic, LLC $15,183 6 $0 (2021)
CooperSurgical, Inc. $14,976 11 $0 (2019)
Exeltis, USA Inc. $4,191 6 $0 (2024)
PFIZER INC. $2,732 5 $0 (2023)
Afaxys, Inc. $1,656 2 $0 (2017)
Merck Sharp & Dohme Corporation $1,105 4 $0 (2018)
Medicines360 $461.98 3 $0 (2018)
Gen-Probe, Inc. $99.82 1 $0 (2019)
Bayer HealthCare Pharmaceuticals Inc. $93.67 5 $0 (2018)
Novo Nordisk Inc $32.27 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,010 2 Exeltis, USA Inc. ($3,010)
2023 $731.42 4 PFIZER INC. ($567.85)
2022 $2,164 3 PFIZER INC. ($2,164)
2021 $3,500 1 Hologic, LLC ($3,500)
2020 $12,755 9 Hologic, LLC ($11,683)
2019 $2,119 3 CooperSurgical, Inc. ($2,019)
2018 $13,392 13 CooperSurgical, Inc. ($12,957)
2017 $2,881 10 Afaxys, Inc. ($1,656)

All Payment Transactions

45 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/04/2024 Exeltis, USA Inc. SLYND (Drug) Consulting Fee Cash or cash equivalent $2,950.95 General
Category: CONTRACEPTIVE
09/09/2024 Exeltis, USA Inc. Food and Beverage In-kind items and services $58.58 General
05/22/2023 Novo Nordisk Inc Wegovy (Drug) Education In-kind items and services $32.27 General
Category: Obesity
04/22/2023 PFIZER INC. MYFEMBREE (Drug) Food and Beverage In-kind items and services $381.18 General
Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH
04/22/2023 PFIZER INC. MYFEMBREE (Drug) Travel and Lodging In-kind items and services $186.67 General
Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH
03/27/2023 Exeltis, USA Inc. SLYND (Drug) Food and Beverage In-kind items and services $131.30 General
Category: Oral Contraceptive
09/17/2022 PFIZER INC. MYFEMBREE (Drug) Travel and Lodging In-kind items and services $1,456.99 General
Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH
09/17/2022 PFIZER INC. MYFEMBREE (Drug) Travel and Lodging In-kind items and services $507.46 General
Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH
09/17/2022 PFIZER INC. MYFEMBREE (Drug) Food and Beverage In-kind items and services $199.85 General
Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH
09/06/2021 Hologic, LLC Consulting Fee Cash or cash equivalent $3,500.00 General
12/30/2020 Exeltis, USA Inc. SLYND (Drug) Consulting Fee Cash or cash equivalent $700.00 General
Category: Oral Contraceptive
09/18/2020 Exeltis, USA Inc. SLYND (Drug) Consulting Fee Cash or cash equivalent $175.00 General
Category: Oral Contraceptive
08/20/2020 Exeltis, USA Inc. SLYND (Drug) Consulting Fee Cash or cash equivalent $175.00 General
Category: Oral Contraceptive
05/02/2020 Hologic, LLC Consulting Fee Cash or cash equivalent $7,682.50 General
05/02/2020 Hologic, LLC Consulting Fee Cash or cash equivalent $2,000.00 General
03/16/2020 Hologic, LLC Consulting Fee Cash or cash equivalent $750.00 General
03/06/2020 Cytyc Surgical Products, LLC Food and Beverage In-kind items and services $22.11 General
02/13/2020 Hologic, LLC Consulting Fee Cash or cash equivalent $750.00 General
02/13/2020 Hologic, LLC Consulting Fee Cash or cash equivalent $500.00 General
07/25/2019 Gen-Probe, Inc. Co testing (Device), Aptima HPV, Aptima M genitalium Food and Beverage In-kind items and services $99.82 General
Category: Diagnostics
05/01/2019 CooperSurgical, Inc. Paragard (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: Endocrinology
05/01/2019 CooperSurgical, Inc. Paragard (Device) Food and Beverage In-kind items and services $19.46 General
Category: Endocrinology
12/31/2018 Medicines360 Liletta (Device) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $200.00 General
Category: Obstetrics/Gynecology (Women's Health)
12/01/2018 CooperSurgical, Inc. Paragard (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,750.00 General
Category: Endocrinology
12/01/2018 CooperSurgical, Inc. Paragard (Device) Travel and Lodging Cash or cash equivalent $210.00 General
Category: Endocrinology

About Dr. Larry Glazerman, MD

Dr. Larry Glazerman, MD is a Obstetrics & Gynecology healthcare provider based in Wilmington, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356397574.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Glazerman, MD has received a total of $40,552 in payments from pharmaceutical and medical device companies, with $3,010 received in 2024. These payments were reported across 45 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($19,183).

Practice Information

  • Specialty Obstetrics & Gynecology
  • Other Specialties Obstetrics & Gynecology, Obstetrics & Gynecology
  • Location Wilmington, DE
  • Active Since 05/26/2006
  • Last Updated 06/08/2015
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1356397574

Products in Payments

  • Paragard (Device) $14,976
  • SLYND (Drug) $4,132
  • MYFEMBREE (Drug) $2,732
  • ella (Drug) $1,656
  • NEXPLANON (Drug) $1,070
  • Liletta (Device) $461.98
  • Co testing (Device) $99.82
  • Kyleena (Drug) $56.65
  • Wegovy (Drug) $32.27
  • Essure (Device) $21.32
  • NUVARING (Drug) $19.32
  • Mirena (Drug) $15.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Wilmington